Soluble in DMSO (up to 30 mg/ml) or in DMF (up to 50 mg/ml).
Aparência
White or off-white solid
Condições de armazenamento
-20°C
Indicação
Anti-cancer
Descrição do produto
Baricitinib (1187594-09-7), approved by the FDA for two inflammatory disorders, rheumatoid arthritis and alopecia areata, selectively inhibits Janus kinase 1 (IC50?= 5.9 nM) and 2 (5.7 nM), over 3 (0.56 μM).1
